About Us

Board of directors

Gilles Avenard, MD – CEO & Chairman of the Board

Board member or advisor for several biotech companies ; co-founder and COO of BioAlliance Pharma SA – ONXEO (NYSE EURONEXT) until 2010. Gilles Avenard was involved in the development of several innovative medicines until their registration in Europe and the USA. Before that, he was Projects Director for Hoechst Marion Roussel (Sanofi) and Medical Director of Bio-Transfusion (LFB).

Catherine Boule – CapDecisif Management

Partner at CapDecisif Management, Catherine Boule holds a Master of Science in Molecular Biology from the University Paris VI and a degree in “Management of Technological Innovation in Bio-Industries ” from the INA Paris-Grignon / Reims Management School. She worked at the Curie Institute (CNRS) in Paris before working with innovative biotechnology start-ups for an incubator in the Paris region.

Jean Pierre Cazenave, MD – Director

Honorary Professor of Hematology and Transfusion (University of Strasbourg), President of ARMESA, a Strasbourg medical research Association and member of the French Académie Nationale de Médecine. After his MD degree (1970, University of Strasbourg), he moved to Canada at Mac Master University, Ontario, where he worked on platelet physiology and pharmacology for a PhD and was appointed Assistant Professor of Pathology. Back to Strasbourg Blood Transfusion Center (1978) to create an INSERM research unit (U311) in 1986 devoted to the Biology and Pharmacology of Hemostasis and Thrombosis. From 1987 to 2013, he has been the Director of the Blood Transfusion Center of EFS-Alsace in Strasbourg. He is a past president (1992-1995) and vice- president (2002-2010) of the Société Française de Transfusion Sanguine. He is member of several international medical societies, and author of more than 600 scientific publications.

Christophe Pasik, MD – Director

Christophe is the co Founder (in 2006) and current CEO of Keocyt SAS a French pharmaceutical company. He is an active Business Angel, co founder of several healthcare societies and Board member of French Biotech and Healthcare companies. Prior to that and since 1990, he held various positions in Pharma companies such as Pfizer, Pharmacia, Catalent and Merck Lipha in France and abroad.